Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

Annals of Oncology : Official Journal of the European Society for Medical Oncology
H-J SchmollC Y Chan

Abstract

We compared an aprepitant regimen with a control regimen of ondansetron + dexamethasone given for 4 days. Patients scheduled to receive cisplatin > or =70 mg/m(2) were randomized to either the aprepitant regimen (aprepitant, ondansetron and dexamethasone on day 1; aprepitant and dexamethasone on days 2-3; dexamethasone on day 4) or control regimen (ondansetron + dexamethasone on days 1-4). Patients recorded vomiting, nausea and rescue therapy use. The primary end point was complete response (no vomiting and no use of rescue therapy) in the overall phase (days 1-5 post-cisplatin). Complete response rates were higher in the aprepitant than control group in the overall (72% versus 61%; P = 0.003), acute (day 1; 88% versus 79%; P = 0.005) and delayed phases (days 2-5; 74% versus 63%; P = 0.004), as were rates of no vomiting (overall 77% versus 62%, P < or = 0.001; acute 89% versus 81%, P = 0.004; delayed 79% versus 64%, P < or = 0.001). Rates of no rescue therapy were similar between groups. Compared with an antiemetic regimen in which ondansetron + dexamethasone were given for 4 days, the aprepitant regimen was superior in the acute, delayed and overall phases of chemotherapy-induced nausea and vomiting. The aprepitant regimen sho...Continue Reading

References

Sep 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R J Gralla
Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I T JantunenT T Muhonen
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J LatreilleB Zee
Jun 13, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·X Garcia-del-MuroP Viladiu
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J GrallaD G Pfister
Nov 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H TsukadaY Kurita
Feb 28, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Fausto RoilaGuido Margutti
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J HeskethK J Horgan
Jul 5, 2003·Clinical Pharmacology and Therapeutics·Jacqueline B McCreaRobert A Blum
Aug 2, 2003·Clinical Pharmacology and Therapeutics·Anup K MajumdarRobert A Blum
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R de WitK J Horgan
May 13, 2004·Cancer·Steven M GrunbergGedske Daugaard
Nov 27, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mark G KrisEnzo Ballatori
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Olga Geling, Hans-Georg Eichler
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David G WarrFranck Skobieranda

❮ Previous
Next ❯

Citations

Jun 18, 2010·Cancer Chemotherapy and Pharmacology·Uday B DandamudiLionel D Lewis
Jul 19, 2013·Cancer Chemotherapy and Pharmacology·Susan SunBrett Duersch
Mar 22, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rudolph M NavariCynthia S Johnson
Oct 30, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lieven AnnemansHughes Malonne
Jul 14, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paul J HeskethAlexandra D Carides
Apr 21, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Suthinee IthimakinApirom Laocharoenkeat
Oct 6, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yan JinJinfei Chen
Dec 24, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Muneer H AbidiJoseph Uberti
May 7, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Satoru MiuraHirohisa Yoshizawa
Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Laura García-EstévezAna Lluch
Oct 27, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jesús García GómezUNKNOWN SEOM (Spanish Society for Medical Oncology)
Sep 11, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J García GómezUNKNOWN SEOM
Mar 17, 2010·Indian Pediatrics·Pooja DewanDeepika Harit
Jun 6, 2008·The New England Journal of Medicine·Paul J Hesketh
Jun 23, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F RoilaS M Grunberg
May 22, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M S Aapro, C M Walko
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F RoilaUNKNOWN ESMO/MASCC Guidelines Working Group
Oct 16, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Feyer, K Jordan
Aug 23, 2012·Journal of the National Cancer Institute·Lucas Vieira dos SantosJoão Paulo da Silveira Nogueira Lima
Apr 9, 2008·The Cancer Journal·Lisa Lohr
Aug 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A RoscoeJ Philip Kuebler
Mar 26, 2009·Magyar onkologia·Béla Pikó, Ali Bassam
Sep 2, 2009·Drugs·Monique P Curran, Dean M Robinson
Jan 31, 2008·Current Oncology·D G Warr
Feb 14, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christopher M Hocking, Ganessan Kichenadasse
Apr 22, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yasuhiro ItoKingo Chida
Jun 17, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Flavia LongoMarisa Di Seri
May 6, 2014·Experimental Brain Research·Erin M RockLinda A Parker
May 16, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nobuhiro TakeshimaKimihiko Ito
May 20, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Thomas BechtelSteven M Devine
Oct 12, 2011·Disaster Medicine and Public Health Preparedness·Nicholas DainiakViktor Meineke
Jul 24, 2013·Expert Opinion on Pharmacotherapy·Antonio Macciò, Clelia Madeddu
Nov 26, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kamalesh K SankhalaSant P Chawla
May 28, 2013·Expert Opinion on Drug Safety·Miguel Muñoz, Rafael Coveñas
Mar 23, 2011·Expert Opinion on Drug Safety·Christina H Ruhlmann, Jørn Herrstedt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
David G WarrKevin J Horgan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
American Society of Clinical OncologySteven M Grunberg
© 2021 Meta ULC. All rights reserved